Siva Therapeutics Completes Efficacy Study in Melanoma Model and Files FDA Pre-Submission

BOULDER, COLORADO, July 10, 2013 – Siva Therapeutics Inc (‘Siva’) has generated very positive efficacy results in a challenging mouse melanoma model, using SivaRods™ photothermal therapy. In the study, significant decreases in tumor volume and increased survival, relative to control animals, were seen.  Continue reading “Siva Therapeutics Completes Efficacy Study in Melanoma Model and Files FDA Pre-Submission”

Siva Therapeutics Closes Angel Financing Round, Moves into New Facilities

BOULDER, COLORADO, December 3, 2012 –Siva Therapeutics has closed an initial angel financing round; this funding, together with a recent $350,000 grant from Breakout Labs, has enabled Siva to expand operations and to undertake a new series of studies on its nanotechnology enabled photothermal therapy. With this financing in place, Siva has hired a Bioengineer Continue reading “Siva Therapeutics Closes Angel Financing Round, Moves into New Facilities”

Siva Therapeutics Licenses ‘Smart Polymer’ Technology from Colorado School of Mines

BOULDER, COLORADO, September 6, 2012 –Siva Therapeutics has signed an option agreement for a co-exclusive license to a published US patent application entitled ‘Gold Nanoparticle Conjugates and Uses Thereof’ with the Technology Transfer Office at the Colorado School of Mines (CSM). Continue reading “Siva Therapeutics Licenses ‘Smart Polymer’ Technology from Colorado School of Mines”

Siva Therapeutics add key Business and Scientific Advisors

BOULDER, COLORADO, September 1, 2012–Siva Therapeutics has added two prestigious advisors to it team – one each to the Business and Scientific Advisory Boards.

Ron Eller, an experienced CEO/general manager with a demonstrated track record in turnarounds and in building teams that grow businesses, has joined our Business Advisory Board. Continue reading “Siva Therapeutics add key Business and Scientific Advisors”

Siva Therapeutics Selected as a Company to Watch at the Angel Capital Summit in Denver, CO

BOULDER, COLORADO, April 4, 2012–Siva Therapeutics was selected as a company to watch by a panel of investors at the Angel Capital Summit (ACS) in Denver, CO. Out of 40 presenting companies, Siva Therapeutics was one of 13 companies selected to the watch list by investors during the Denver Investor Forum that took place following the ACS presentations. Continue reading “Siva Therapeutics Selected as a Company to Watch at the Angel Capital Summit in Denver, CO”

Siva Therapeutics Inc will present at the Angel Capital Summit in Denver, CO

BOULDER, COLORADO, March 20, 2012– Siva Therapeutics announced today it has been selected topresent at the Angel Capital Summit held at the University of Denver. The Angel Capital Summit is athree day event at the University of Denver designed to connect investors with entrepreneurs. Theevent contains workshops for entrepreneurs, speakers, investor forums, and popular networking events. Continue reading “Siva Therapeutics Inc will present at the Angel Capital Summit in Denver, CO”